What an FDA Head Who Opposes Abortion Pills and Vaccines Would Mean for Your Health

Dr. Heidi Overton's nomination to lead the FDA puts three pillars of public health at stake: access to reproductive medicine, childhood vaccination rates, and food safety oversight.

By Common Good Policy Team · September 25, 2026 · Responding to New York Times (September 24, 2026)

What Happened

Dr. Heidi Overton is facing a Senate confirmation hearing for nomination as FDA commissioner, the federal official responsible for approving medicines, vaccines, and food safety for 330 million Americans. According to the New York Times, Overton has called mifepristone, the medication used in medication abortion, "dangerous to women," and during her time as a White House aide, she worked to reduce the number of vaccines recommended for children.

This is not a routine personnel matter. The FDA commissioner wields enormous power over what medicines reach patients, what vaccines doctors can recommend, and whether the food supply is safe to eat. The nominee's record suggests she would use that power to restrict access to abortion medication and to challenge scientific vaccine recommendations.

What It Means for You

If confirmed, Overton would control the agency that currently allows mifepristone to be used safely under FDA-approved protocols. As of 2024, medication abortion accounts for more than half of all U.S. abortions, according to data from the Guttmacher Institute. She would also oversee the CDC's vaccine recommendation process, the system that has eliminated diseases like polio and dramatically reduced childhood deaths from measles, mumps, and rubella.

For people seeking abortion care: Overton's opposition to mifepristone isn't academic. Sixty-two point seven million women already live under state-level abortion bans, according to Common Good Party analysis. An FDA commissioner hostile to medication abortion could tighten approval rules, impose new restrictions, or fail to defend the drug against legal challenges. This would eliminate access for millions more.

For parents: Vaccine recommendations aren't invented by bureaucrats. They're built on decades of safety monitoring and disease surveillance. If Overton's goal is to reduce the number of recommended vaccines, a position she reportedly advocated as a White House aide, she would be overruling epidemiologists and pediatricians based on ideology, not evidence. The immediate consequence would be lower vaccination rates. The longer-term consequence would be the return of diseases that modern America has nearly eliminated.

For everyone eating food: The FDA's food safety division has roughly 900 investigators covering roughly 150,000 food facilities across the country. A commissioner opposed to strong regulation could mean fewer inspections, slower responses to contamination, and a weaker guardrail between your dinner table and foodborne illness. The agency already struggles with resources; ideological skepticism of its mission would make that worse.

The Bigger Picture

This nomination reflects a broader pattern: the politicization of agencies built to serve health, not ideology. The FDA exists because in the early 1900s, Americans died from contaminated meat and untested patent medicines. The vaccine schedule exists because measles killed 500 Americans a year in the 1960s. Mifepristone received FDA approval in 2000 based on clinical evidence showing it was safer than the surgical alternative.

These aren't partisan achievements. They're evidence-based public health. A commissioner who calls a medicine "dangerous to women" without citing clinical evidence, or who seeks to reduce vaccine recommendations against the advice of immunologists, is not leading an agency. She's running an ideology shop with a federal budget.

The timing matters too. In 2026, as the midterms approach, nominees like Overton signal which direction an administration intends to move. A hostile FDA commissioner would spend the next two years rewriting rules on abortion access, vaccine requirements, and food oversight. By the time voters understand what happened, the damage could be structural.

Where This Goes

Senate confirmation depends on whether enough senators believe the FDA's job is to protect public health or to enforce a particular moral vision. The hearing will likely feature claims about mifepristone's safety record and the evidence behind vaccine recommendations. Those claims matter because the decisions that follow, approval, restriction, or removal, affect real people: the teenager in a ban state seeking medication abortion, the parent deciding whether to vaccinate, the family buying groceries.

The Common Good Party believes the FDA should be led by someone committed to evidence first. That's not a left-right issue. It's a competence issue. If you're sick, you want a doctor reading the data, not a politician reading a script. The same is true for the person leading the agency that approves what doctors can prescribe.

Read on The Common Good Party